Supreme Court Temporarily Preserves Access to Abortion Pill
PUBLISHED May 11, 2026, 4:49 PM ET
Read, Watch or Listen
Washington — The Supreme Court on Monday issued an administrative order temporarily leaving access to the abortion pill mifepristone unchanged while the justices consider whether to permit restrictions imposed by a federal appeals court to take effect. Justice Samuel Alito's order prevents immediate enforcement of the appeals-court limitations and keeps pharmacy and mail distribution available. The action follows litigation filed by Louisiana challenging FDA prescribing rules and a three-judge panel of the 5th U.S. Circuit Court of Appeals that concluded the state was likely to prevail. The Supreme Court has preserved the status quo through at least Thursday as it evaluates the legal arguments, with potential further rulings expected later this week.
By Lauren Mitchell | JQJO News
Timeline of Events
- 2000 — FDA approves mifepristone for medical abortion use.
- 2022 — Supreme Court overturns Roe v. Wade, changing state abortion authority.
- Louisiana files suit challenging FDA mifepristone prescribing rules (post-Dobbs).
- A three-judge panel of the 5th U.S. Circuit Court of Appeals limits aspects of mifepristone distribution.
- Monday — Justice Alito issues temporary order keeping access intact until at least Thursday while the Supreme Court reviews the case.
News Intelligence
- This case impacts access to the abortion pill mifepristone. If restrictions are imposed, it could affect how and where you can get the pill. Keep an eye on the Supreme Court's decision this week. It's your health and rights at stake.
- Articles Published:
- 5
- Right Leaning:
- 0
- Left Leaning:
- 0
- Neutral:
- 5
- Distribution:
- Left 0%, Center 100%, Right 0%
Women seeking medication abortions, pharmacies, and clinicians benefited when the Supreme Court issued a temporary order preserving access to mifepristone through pharmacies and by mail, preventing immediate enforcement of appeals-court restrictions.
Louisiana and plaintiffs challenging FDA prescribing rules experienced a delay in enforcing lower-court restrictions when the Supreme Court paused those limits pending further review.
Coverage of Story:
From Left
No left-leaning sources found for this story.
From Center
Supreme Court Temporarily Preserves Access to Abortion Pill
The CT Mirror WHDH 7 Boston LatestLY PBS.org Internewscast JournalFrom Right
No right-leaning sources found for this story.
Comments